TECH OUTLOOK 6NOVEMBER - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe global pharmaceutical industry is growing at an exponential rate. With drug affordability and disease prevalence driving it, the global market for pharmaceuticals is expected to exceed EUR 1.28 trillion in the next couple of years. Germany has already become the epicentre of the European pharmaceutical industry due to the high rating of its finished product manufacturing and the enormous potential. And in the wake of the COVID-19 pandemic and its impact on the global supply chain, discussions have reinvigorated concerning bringing the production of active pharmaceutical ingredients (APIs) and pharmaceuticals back to the European Union, which would again play to the advantage of the nation's pharmaceutical industry. While the pharmaceutical industry has felt the technological transformation in research and development (R&D) over the past few years, it is set to expand in other divisions over the next decade. For instance, companies have already started leveraging artificial intelligence to use cognitive computers in biotechnology and genomic research. Similarly, the growing trend of "around the pill" digital offerings, increasing popularity of 3D printing, and similar technological advancements are transforming the industry at each level. To survive and thrive in this evolving pharmaceutical landscape, it has become essential than ever for the companies to invest in the latest innovations and technological advancements.In this edition of Pharma Tech Outlook, we bring you the story of some of the most promising pharma tech solution and service providers that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best pharma tech solution according to your requirements.Let us know your thoughts!Stepping into a Decade of Technological TransformationCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.NOVEMBER - 12 - 2020, Vol 06 - Issue 26 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerRonald DonovanAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405TECH OUTLOOK
< Page 5 | Page 7 >